(NASDAQ: HCWB) Hcw Biologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.74%.
Hcw Biologics's earnings in 2026 is -$22,298,702.On average, 3 Wall Street analysts forecast HCWB's earnings for 2026 to be -$6,594,035, with the lowest HCWB earnings forecast at -$6,335,445, and the highest HCWB earnings forecast at -$6,787,977. On average, 3 Wall Street analysts forecast HCWB's earnings for 2027 to be -$3,777,832, with the lowest HCWB earnings forecast at -$3,629,682, and the highest HCWB earnings forecast at -$3,888,945.
In 2028, HCWB is forecast to generate -$3,159,642 in earnings, with the lowest earnings forecast at -$3,035,734 and the highest earnings forecast at -$3,252,572.